Crescent Capital BDC (NASDAQ:CCAP) Cut to Neutral at LADENBURG THALM/SH SH

Crescent Capital BDC (NASDAQ:CCAP) was downgraded by LADENBURG THALM/SH SH from a “buy” rating to a “neutral” rating in a research note issued on Wednesday, Marketbeat reports. They currently have a $10.00 price objective on the stock. LADENBURG THALM/SH SH‘s price target points to a potential downside of 1.33% from the company’s previous close.

A number of other equities analysts also recently commented on the stock. Wall Street Zen upgraded shares of Crescent Capital BDC from a “sell” rating to a “hold” rating in a research note on Saturday, October 10th. Bank of America cut Crescent Capital BDC from a “buy” rating to a “neutral” rating and decreased their price objective for the company from $13.00 to $10.25 in a report on Thursday, September 10th. Wells Fargo & Company lowered their target price on Crescent Capital BDC from $11.00 to $10.00 and set an “equal weight” rating on the stock in a research report on Wednesday. Raymond James Financial set a $10.00 target price on Crescent Capital BDC in a research report on Thursday, October 22nd. Finally, B. Riley Financial dropped their target price on Crescent Capital BDC from $13.50 to $12.50 and set a “neutral” rating on the stock in a report on Wednesday, August 12th. Seven analysts have rated the stock with a Hold rating. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $11.54.

Crescent Capital BDC Stock Down 2.4%

Shares of NASDAQ CCAP traded down $0.24 during midday trading on Wednesday, reaching $10.13. The company’s stock had a trading volume of 14,148 shares, compared to its average volume of 230,152. The stock has a 50 day simple moving average of $9.44 and a 200-day simple moving average of $11.53. The company has a current ratio of 1.30, a quick ratio of 1.30 and a debt-to-equity ratio of 1.41. The stock has a market capitalization of $373.47 million, a price-to-earnings ratio of -1,012.50 and a beta of 0.56. Crescent Capital BDC has a fifty-two week low of $8.40 and a fifty-two week high of $15.18.

Crescent Capital BDC (NASDAQ:CCAP) last released its earnings results on Monday, November 9th. The company reported $0.37 earnings per share for the quarter, beating analysts’ consensus estimates of $0.35 by $0.02. Crescent Capital BDC had a negative net margin of 0.10% and a positive return on equity of 8.66%. The business had revenue of $36.89 million during the quarter, compared to the consensus estimate of $36.37 million. Equities research analysts predict that Crescent Capital BDC will post 1.49 earnings per share for the current year.

Insiders Place Their Bets

In other Crescent Capital BDC news, major shareholder & Guaranty Life Insur Fidelity sold 139,054 shares of the company’s stock in a transaction on Wednesday, September 9th. The shares were sold at an average price of $10.23, for a total transaction of $1,422,522.42. Following the sale, the insider directly owned 3,680,307 shares of the company’s stock, valued at approximately $37,649,540.61. This represents a 3.64% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 451,543 shares of company stock worth $4,689,738 in the last 90 days. 1.23% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the company. Condor Capital Management increased its stake in shares of Crescent Capital BDC by 0.7% during the 3rd quarter. Condor Capital Management now owns 281,799 shares of the company’s stock worth $2,587,000 after purchasing an additional 1,840 shares during the last quarter. SMH Capital Advisors Inc. bought a new stake in shares of Crescent Capital BDC in the 3rd quarter valued at about $143,000. Beach Point Capital Management LP lifted its stake in Crescent Capital BDC by 1,301.2% in the 3rd quarter. Beach Point Capital Management LP now owns 515,892 shares of the company’s stock valued at $4,736,000 after purchasing an additional 479,075 shares during the last quarter. TT Capital Management LLC lifted its stake in Crescent Capital BDC by 9.2% in the 3rd quarter. TT Capital Management LLC now owns 27,600 shares of the company’s stock valued at $253,000 after purchasing an additional 2,333 shares during the last quarter. Finally, Adams Asset Advisors LLC lifted its stake in Crescent Capital BDC by 8.4% in the 3rd quarter. Adams Asset Advisors LLC now owns 119,066 shares of the company’s stock valued at $1,093,000 after purchasing an additional 9,238 shares during the last quarter. Institutional investors own 49.46% of the company’s stock.

Trending Headlines about Crescent Capital BDC

Here are the key news stories impacting Crescent Capital BDC this week:

• Positive Sentiment: Quarterly results beat expectations. CCAP reported Q3 net investment income of $0.37 per share, above the $0.35 consensus, and revenue of $36.89 million versus estimates of $36.37 million. Earnings were still below $0.46 per share a year earlier. Q3 earnings report
• Positive Sentiment: Buyback and dividend may support shareholder returns. The company authorized a $50 million share repurchase program and declared a quarterly base dividend of $0.34 per share, equivalent to $1.36 annualized. The announced dividend yield was about 13.1%, though dividends and yields can change. Company earnings and capital-return announcement
• Neutral Sentiment: Analyst outlooks diverge. One Zacks report cited an average analyst price target implying 34.3% upside, while Wells Fargo lowered its target from $11 to $10 and kept an equal-weight rating. The target cut suggests limited near-term upside in that analyst’s view. Analyst consensus report
• Negative Sentiment: Buyout-lending activity weakened. Direct lending for buyouts fell 60% year over year, raising concerns about deal flow and future investment opportunities. Investors will also watch for the company’s targeted Q4 2026 joint-venture completion. Long-term investor takeaways

About Crescent Capital BDC

Crescent Capital BDC, Inc. is a business development company that provides financing to middle-market companies. The company seeks to generate current income and, to a lesser extent, capital appreciation by investing in privately negotiated debt and equity securities. Its investment portfolio is focused primarily on senior secured loans, including first-lien and second-lien loans, as well as other debt investments and selected equity interests. Crescent Capital BDC generally works with established companies across a range of industries, providing capital for acquisitions, recapitalizations, refinancing, growth initiatives and other corporate purposes.